切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2015, Vol. 04 ›› Issue (03) : 169 -172. doi: 10.3877/cma.j.issn.2095-3232.2015.03.009

所属专题: 文献

临床研究

围手术期强化气道管理在预防肝移植术后肺部感染中的应用价值
安玉玲1, 易小猛1, 魏绪霞1, 吕海金1, 刘剑戎1, 易慧敏1,()   
  1. 1. 510630 广州,中山大学附属第三医院肝移植中心
  • 收稿日期:2015-03-06 出版日期:2015-06-10
  • 通信作者: 易慧敏
  • 基金资助:
    广东省自然科学基金(S2013010016785); 广州市科技计划项目(2011Y1-00033-1)

Application value of perioperative intensive airway management in prevention of lung infection after liver transplantation

Yuling An1, Xiaomeng Yi1, Xuxia Wei1, Haijin Lyu1, Jianrong Liu1, Huimin Yi1,()   

  1. 1. Liver Transplantation Center, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China
  • Received:2015-03-06 Published:2015-06-10
  • Corresponding author: Huimin Yi
  • About author:
    Corresponding author: Yi Huimin, Email:
引用本文:

安玉玲, 易小猛, 魏绪霞, 吕海金, 刘剑戎, 易慧敏. 围手术期强化气道管理在预防肝移植术后肺部感染中的应用价值[J]. 中华肝脏外科手术学电子杂志, 2015, 04(03): 169-172.

Yuling An, Xiaomeng Yi, Xuxia Wei, Haijin Lyu, Jianrong Liu, Huimin Yi. Application value of perioperative intensive airway management in prevention of lung infection after liver transplantation[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2015, 04(03): 169-172.

目的

探讨围手术期强化气道管理在预防肝移植术后肺部感染中的应用价值。

方法

回顾性分析2004年1月至2014年9月在中山大学附属第三医院实施肝移植术的914例患者临床资料。所有患者均签署知情同意书,符合医学伦理学规定。患者术后均转ICU监护治疗,根据围手术期有否进行强化气道管理,分为实行气道管理组(研究组)和未实行气道管理组(对照组)。其中研究组170例,男152例,女18例;平均年龄(48±11)岁。对照组744例,男655例,女89例;年龄(49±12)岁。强化气道管理措施主要包括加强拍背咳痰和呼吸功能锻炼、保持胃肠减压引流通畅、防止误吸、湿化气道、无菌吸痰等基础护理,缩短呼吸机使用时间,麻醉清醒后12~24 h内雾化吸入布地奈德、氨溴索,必要时行纤维支气管镜吸痰治疗,保证气道痰液有效排出。比较两组患者术后1个月内的肺部感染发生率和病死率。两组感染发生率和病死率的比较采用χ2检验。

结果

研究组患者术后1个月的肺部感染发生率为17.1%(29/170),明显低于对照组的28.9%(215/744) (χ2=9.91,P<0.05)。研究组患者术后1个月的病死率为4.1%(7/170),明显低于对照组的10.1%(75/744) (χ2=6.03,P<0.05)。

结论

围手术期强化气道管理能明显降低肝移植术后肺部感染发生率和病死率。

Objective

To investigate the application value of perioperative intensive airway management in prevention of lung infection after liver transplantation (LT).

Methods

Clinical data of 914 patients undergoing LT in the Third Affiliated Hospital of Sun Yat-sen University between January 2004 and September 2014 were retrospectively studied. The informed consents of all patients were obtained and the local ethical committee approval had been received. All patients were transferred into ICU after LT. According to whether the intensive airway management was performed during the perioperative period, the patients were divided into the group with airway management (the study group) and the group without airway management (the control group). Among the 170 patients of study group, 152 were males and 18 were females with the average age of (48±11) years old. Among the 744 patients of control group, 655 were males and 89 were females with the average age of (49±12) years old. The measures of intensive airway management included the basic nursing of strengthening back-slapping for excreting phlegm and respiratory function exercise, maintaining gastrointestinal decompression and clear drainage, preventing aspiration, moistening airway, aseptic suction, also included reducing the use of ventilator, giving aerosol inhalation of budesonide and ambroxol within 12-24 h after anesthetic awareness, performing sputum suction by fiberoptic bronchoscopy when necessary to ensure sputum excretion from airway. The incidence of lung infection and mortality within 1 month after LT of the two groups were compared. The infection incidence and mortality between two groups were compared using Chi-square test.

Results

The incidence of lung infection of study group was 17.1% (29/170), which was significantly lower than 28.9% (215/744) of control group (χ2=9.91, P<0.05). The mortality 1 month after LT of study group was 4.1% (7/170), which was significantly lower than 10.1% (75/744) of control group (χ2=6.03, P<0.05).

Conclusion

Perioperative intensive airway management can significantly reduces the incidence of perioperative lung infection and mortality after LT.

表1 研究组和对照组肝移植患者基线资料比较(±s
[1]
Bozbas SS, Yilmaz EB, Dogrul I, et a1.Preoperative pulmonary evaluation of liver transplant candidates: results from 341 adult patients[J]. Ann Transplant, 2011, 16(3): 88-96.
[2]
Aldenkortt F, Aldenkortt M, Caviezel L, et al. Portopulmonary hypertension and hepatopulmonary syndrome[J]. World J Gastroenterol, 2014, 20(25): 8072-8081.
[3]
中华人民共和国卫生部.医院感染诊断标准(试行)[J].中华医学杂志,2001, 81(5): 314-320.
[4]
Jiang GQ, Peng MH, Yang DH. Effect of perioperative fluid therapy on early phase prognosis after liver transplantation[J]. Hepatobiliary Pancreat Dis Int, 2008, 7(4): 367-372.
[5]
Feltracco P, Carollo C, Barbieri S, et al. Early respiratory complications after liver transplantation[J]. World J Gastroenterol, 2013, 19(48): 9271-9281.
[6]
Saner FH, Akkiz H, Canbay A. Infectious complications in the early postoperative period in liver transplant patients[J]. Minerva Gastroenterol Dietol, 2010, 56(3): 355-365.
[7]
时军,丁利民.肝移植后肺部感染的因素分析及防治[J/CD].中华普通外科学文献:电子版,2010, 4(5):450-452.
[8]
刘非,李波,冯曦,等.成人间活体肝移植受体术后肺部感染分析[J].中华肝脏病杂志,2009, 17(8):611-614.
[9]
Khemani RG, Randolph A, Markovitz B. Corticosteroids for the prevention and treatment of post-extubation stridor in neonates, children and adults[J]. Cochrane Database Syst Rev, 2009(3): CD001000.
[10]
支修益,卫生部临床路径专家委员会胸外科专家组.胸外科围手术期气道管理专家共识(2012年版)[J].中国胸心血管外科临床杂志,2013, 20(3): 251-255.
[11]
Dolovich MB, Ahrens RC, Hess DR,et al. Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology[J]. Chest, 2005, 127(1): 335-371.
[12]
Eyüboğlu FÖ, Küpeli E, Bozbaş SS, et al. Evaluation of pulmonary infections in solid organ transplant patients: 12 years of experience[J]. Transplant Proc, 2013, 45(10): 3458-3461.
[13]
刘莉娟.机械通气下经纤支镜吸痰并肺段灌洗术配合静脉抗生素治疗重症肺炎的临床观察[J].中国医学创新,2013(3): 41-42.
[14]
张辉,张小燕,何彩霞,等.经纤支镜肺泡灌洗治疗机械通气下重症肺部感染的疗效观察[J].中国现代医生,2014, 52(1): 140-142.
[15]
徐志丹,时军,罗文峰,等.肝脏移植术后肺部感染的防治[J].实用临床医学,2010, 11(5): 28-31.
[16]
易慧敏,蔡常洁,陆敏强,等.肝移植术后急性肺损伤的治疗策略[J].中华外科杂志,2006, 44(13): 889-893.
[17]
Chihara Y, Egawa H, Tsuboi T, et al. Immediate noninvasive ventilation may improve mortality in patients with hepatopulmonary syndrome after liver transplantation[J]. Liver Transpl, 2011, 17(2): 144-148.
[18]
郭润玲,郭爱芝,王颖,等.Venturi+MR850氧疗在气管插管病人拔管中的应用[J].护理研究,2014(21): 2636-2637.
[19]
陈丽,黄志宏,吴义,等.激素对慢性阻塞性肺疾病患儿IL-8和LTB4及肺功能的影响[J].暨南大学学报:自然科学与医学版,2010, 31(2): 186-189, 202.
[20]
Agarwal R, Aggarwal AN, Gupta D, et al. Inhaled corticosteroids vs placebo for preventing COPD exacerbations: a systematic review and metaregression of randomized controlled trials[J].Chest, 2010, 137(2): 318-325.
[1] . 肝移植治疗终末期肝病[J]. 中华危重症医学杂志(电子版), 2023, 16(04): 1-.
[2] 罗晨, 宗开灿, 李世颖, 傅应亚. 微小RNA-199a-3p调控CD4T细胞表达参与肺炎支原体肺炎患儿免疫反应研究[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 569-574.
[3] 李坤河, 寇萌佳, 邝立挺. 肝移植术后二次气管插管的危险因素及预测模型的建立[J]. 中华普通外科学文献(电子版), 2023, 17(05): 366-371.
[4] 中华医学会器官移植学分会, 中国医师协会器官移植医师分会, 上海医药行业协会. 中国肝、肾移植受者霉酚酸类药物应用专家共识(2023版)[J]. 中华移植杂志(电子版), 2023, 17(05): 257-272.
[5] 陆闻青, 陈昕怡, 任雪飞. 遗传代谢病儿童肝移植受者术后生活质量调查研究[J]. 中华移植杂志(电子版), 2023, 17(05): 287-292.
[6] 范铁艳, 李君, 陈虹. 肝移植术后新发戊型病毒性肝炎的诊治经验[J]. 中华移植杂志(电子版), 2023, 17(05): 293-296.
[7] 陈朔, 陈峰, 程飞, 项捷. 糖原累积病Ⅰ型并发胰腺炎肝移植术后胰腺梗死一例[J]. 中华移植杂志(电子版), 2023, 17(05): 300-302.
[8] 汤鹏昊, 张武. 肠道微生态与肝移植围手术期并发症相关研究进展[J]. 中华移植杂志(电子版), 2023, 17(05): 303-307.
[9] 中国器官移植发展基金会器官移植受者健康管理专家委员会, 中国医师协会器官移植医师分会, 中华医学会器官移植学分会, 国家肝脏移植质控中心. 肝移植受者雷帕霉素靶蛋白抑制剂临床应用中国专家共识(2023版)[J]. 中华移植杂志(电子版), 2023, 17(04): 193-204.
[10] 严庆, 刘颖, 邓斐文, 陈焕伟. 微血管侵犯对肝癌肝移植患者生存预后的影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 624-629.
[11] 廖梅, 张红君, 金洁玚, 吕艳, 任杰. 床旁超声造影对肝移植术后早期肝动脉血栓的诊断价值[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 630-634.
[12] 李秉林, 吕少诚, 潘飞, 姜涛, 樊华, 寇建涛, 贺强, 郎韧. 供肝灌注液病原菌与肝移植术后早期感染的相关性分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 656-660.
[13] 吕垒, 冯啸, 何凯明, 曾凯宁, 杨卿, 吕海金, 易慧敏, 易述红, 杨扬, 傅斌生. 改良金氏评分在儿童肝豆状核变性急性肝衰竭肝移植手术时机评估中价值并文献复习[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 661-668.
[14] 王孟龙. 肿瘤生物学特征在肝癌肝移植治疗中的意义[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 490-494.
[15] 王晓东, 汪恺, 葛昭, 丁忠祥, 徐骁. 计算机视觉技术在肝癌肝移植疗效提升中的研究进展[J]. 中华肝脏外科手术学电子杂志, 2023, 12(04): 361-366.
阅读次数
全文


摘要